2-(3-CHLORO-4-CYCLOPROPYLPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95%, 250mg

MENAQUINONE 7, 97%, 1g

3-Fluoro-4-methylbenzamide, 95.0%, 1g

Lubiprostone>97.0%(HPLC)10mg

1-(tert-Butoxycarbonyl)-4-oxopiperidine-2-carboxylic acid, 95.0%, 5g

2-Bromo-5-(hydroxymethyl)phenol, 95.0%, 25g

3-Oxetanyl p-Toluenesulfonate>98.0%(GC)25g

2H-1,3-benzodioxol-5-ol, 98.0%, 25g

[(tert-butoxy)carbonyl]({[4-(dimethyliminiumyl)-1,4-dihydropyridin-1-yl]sulfonyl})azanide, 98%, 10g

2,4-Dinitrophenylsulfenyl Chloride>96.0%(T)5g

(S)-2-Amino-3-((S)-2-oxopyrrolidin-3-yl)propanenitrile hydrochloride, 98%, 250mg

3-(2,6-Difluorophenyl)-1,2-oxazol-5-amine, 95%, 1g

10-Undecen-1-ol>98.0%(GC)500mL